Allspring Global Investments Holdings, LLC Acadia Pharmaceuticals Inc Transaction History

Allspring Global Investments Holdings, LLC

$54.8 Billion
Q2 2025

A detailed history of Allspring Global Investments Holdings, LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 430,963 shares of ACAD stock, worth $11 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

430,963

Previous 310,332 38.87%

Holding current value

$11 Million

Previous $5.15 Million 80.35%

% of portfolio

0.02%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 25, 2025	BUY	$14.1 - $22.95 $1.7 Million - $2.77 Million	120,631 Added 38.87%	430,963 $9.3 Million
Q1 2025 Apr 24, 2025	BUY	$16.61 - $20.29 $4.46 Million - $5.45 Million	268,714 Added 645.67%	310,332 $5.15 Million
Q4 2024 Jan 29, 2025	SELL	$14.29 - $18.76 $1.14 Million - $1.5 Million	-80,007 Reduced 65.78%	41,618 $763,000
Q3 2024 Oct 18, 2024	BUY	$15.14 - $19.14 $193,595 - $244,743	12,787 Added 11.75%	121,625 $1.87 Million
Q2 2024 Jul 26, 2024	BUY	$14.62 - $18.42 $730,883 - $920,852	49,992 Added 84.95%	108,838 $1.77 Million
Q1 2024 Apr 18, 2024	SELL	$17.79 - $30.86 $1.57 Million - $2.72 Million	-88,253 Reduced 60.0%	58,846 $1.09 Million
Q4 2023 Jan 25, 2024	BUY	$20.78 - $31.77 $457,326 - $699,194	22,008 Added 17.59%	147,099 $4.61 Million
Q3 2023 Oct 27, 2023	BUY	$20.84 - $33.47 $2.61 Million - $4.19 Million	125,091 New	125,091 $2.61 Million
Q2 2023 Jul 18, 2023	SELL	$17.8 - $25.65 $908,316 - $1.31 Million	-51,029 Reduced 57.33%	37,980 $909,000
Q1 2023 Apr 13, 2023	BUY	$16.32 - $20.92 $1.3 Million - $1.67 Million	79,670 Added 853.09%	89,009 $1.68 Million
Q4 2022 Jan 23, 2023	SELL	$14.2 - $18.63 $35,684 - $46,817	-2,513 Reduced 21.2%	9,339 $0
Q3 2022 Oct 26, 2022	BUY	$14.11 - $18.27 $818 - $1,059	58 Added 0.49%	11,852 $193,000
Q2 2022 Jul 25, 2022	SELL	$13.01 - $27.22 $656,562 - $1.37 Million	-50,466 Reduced 81.06%	11,794 $166,000
Q1 2022 May 02, 2022	BUY	$20.94 - $27.5 $70,128 - $92,097	3,349 Added 5.68%	62,260 $0
Q4 2021 Jan 28, 2022	BUY	$16.79 - $27.09 $989,115 - $1.6 Million	58,911 New	58,911 $1.37 Million

Others Institutions Holding ACAD

# of Institutions

348

Shares Held

164M

Call Options Held

1.8M

Put Options Held

337K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $4.12B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Account

Allspring Global Investments Holdings, LLC Acadia Pharmaceuticals Inc Transaction History